Evidence map›Paper›PMID 24975416›Full record

ArticleThe Journal of biological chemistry2014

The α-subunit regulates stability of the metal ion at the ligand-associated metal ion-binding site in β3 integrins.

Xianliang Rui, Mehrdad Mehrbod, Johannes F Van Agthoven, Saurabh Anand, Jian-Ping Xiong, Mohammad R K Mofrad, M Amin Arnaout

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. β2 Integrins-Multi-Functional Leukocyte Receptors in Health and Disease.International journal of molecular sciences · 2020
    Review
  2. Review
  3. Review
  4. αIIbβ3: structure and function.Journal of thrombosis and haemostasis : JTH · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Xianliang RuiLeukocyte Biology and Inflammation Program and Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts 02129.
Mehrdad MehrbodDepartments of Bioengineering and Mechanical Engineering, University of California, Berkeley, California 94720.
Johannes F Van AgthovenStructural Biology Program, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts 02129 and.
Saurabh AnandLeukocyte Biology and Inflammation Program and Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts 02129.
Jian-Ping XiongStructural Biology Program, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts 02129 and.
Mohammad R K MofradDepartments of Bioengineering and Mechanical Engineering, University of California, Berkeley, California 94720. Electronic address: mofrad@berkeley.edu.
M Amin ArnaoutLeukocyte Biology and Inflammation Program and Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts 02129; Structural Biology Program, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts 02129 and. Electronic address: aarnaout1@mgh.harvard.edu.
Massachusetts General Hospital · USHarvard University · USUniversity of California, Berkeley · US

Funding

TRAINING IN CELL STRUCTURE AND FUNCTION IN NEPHROLOGYT32DK007540 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI BROWN, DENNIS, SOBERMAN, ROY · 1986 to 2021
$7.2M
Structure and Function of Integrins in the KidneyR01DK088327 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI ARNAOUT, M. AMIN · 2010 to 2025
$5.3M
Identification of Novel integrin antagonistsR21DK096334 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI ARNAOUT, M. AMIN · 2012 to 2013
$534k
NIDDK NIH HHS DK007540NIDDK NIH HHS DK088327NIDDK NIH HHS DK096334NIDDK NIH HHS R01 DK088327NIDDK NIH HHS R21 DK096334NIDDK NIH HHS T32 DK007540
6 · The paper itself

Abstract

The aspartate in the prototypical integrin-binding motif Arg-Gly-Asp binds the integrin βA domain of the β-subunit through a divalent cation at the metal ion-dependent adhesion site (MIDAS). An auxiliary metal ion at a ligand-associated metal ion-binding site (LIMBS) stabilizes the metal ion at MIDAS. LIMBS contacts distinct residues in the α-subunits of the two β3 integrins αIIbβ3 and αVβ3, but a potential role of this interaction on stability of the metal ion at LIMBS in β3 integrins has not been explored. Equilibrium molecular dynamics simulations of fully hydrated β3 integrin ectodomains revealed strikingly different conformations of LIMBS in unliganded αIIbβ3 versus αVβ3, the result of stronger interactions of LIMBS with αV, which reduce stability of the LIMBS metal ion in αVβ3. Replacing the αIIb-LIMBS interface residue Phe(191) in αIIb (equivalent to Trp(179) in αV) with Trp strengthened this interface and destabilized the metal ion at LIMBS in αIIbβ3; a Trp(179) to Phe mutation in αV produced the opposite but weaker effect. Consistently, an F191/W substitution in cellular αIIbβ3 and a W179/F substitution in αVβ3 reduced and increased, respectively, the apparent affinity of Mn(2+) to the integrin. These findings offer an explanation for the variable occupancy of the metal ion at LIMBS in αVβ3 structures in the absence of ligand and provide new insights into the mechanisms of integrin regulation.

Indexed as

Amino Acid MotifsBinding SitesCations, DivalentHumansIntegrin alphaVbeta3Integrin beta3ManganesePlatelet Glycoprotein GPIIb-IIIa ComplexCations, DivalentIntegrin alphaVbeta3Integrin beta3ITGB3 protein, humanManganesePlatelet Glycoprotein GPIIb-IIIa ComplexCell AdhesionCell BiologyIntegrinMolecular DynamicsSignal Transduction

Identifiers

PMID24975416
PMCPMC4132822
OpenAlexW2016253250

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.